We speculate that beneficial effects of phosphodiesterase @ inhibitors in the systemic vasculature and endothelium were insufficient to improve clinical status or that the deleterious effects on left ventricular function offset any salutary vascular effects , contributing to the absence of benefit observed with sildenafil in subjects with HF and preserved ejection fraction in the RELAX trial .